Ironwood Pharmaceuticals Reports First Quarter 2019 Results; Announces Positive 2019 Adjusted EBITDA from Continuing Operations Guidance

Go back to Ironwood Pharmaceuticals Reports First Quarter 2019 Results; Announces Positive 2019 Adjusted EBITDA from Continuing Operations Guidance
IRONWOOD PHARMA-A (NASDAQ: IRWD) Delayed: 3.83 +0.01 (0.26%)
Previous Close $3.82    52 Week High $16.89 
Open $3.77    52 Week Low $7.35 
Day High $3.92    P/E N/A 
Day Low $3.76    EPS $-2.35 
Volume 715,381